Drug Profile
Vocacapsaicin - Concentric Analgesics
Alternative Names: CA-008; Vocacapsaicin hydrochlorideLatest Information Update: 04 Apr 2022
Price :
$50
*
At a glance
- Originator Concentric Analgesics
- Class Antipruritics; Catechols; Esters; Local anaesthetics; Monounsaturated fatty acids; Non-opioid analgesics; Piperidines; Polyunsaturated alkamides; Small molecules
- Mechanism of Action TRPV1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Postoperative pain
Most Recent Events
- 30 Mar 2022 Efficacy and safety data from a phase II trial in Post-operative pain released by Concentric Analgesics
- 02 Feb 2022 Concentric Analgesics and Evolution Research Group agree for registrational clinical trial of vocacapsaicin for Postoperative pain
- 02 Feb 2022 Concentric Analgesics and University of Rochester Medical Center agree for phase III clinical trials of vocacapsaicin for Postoperative pain